Insider Ledger
INSP insider buying and SEC filings, explained
Inspire Medical Systems, Inc. · CIK 1609550
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$202K
Planned sales (10b5-1)
$464K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 7, 2026 | Sale | Jason P Kelly (Chief Manufacturing and Quality Officer) sold 963 shares at $59.55 ($57K). Holdings down 5% to 18,985 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| May 15, 2026 | Sale | John Rondoni (Chief Product and Innovation Officer) sold 2,641 shares at about $43.28 ($114K). Holdings down 9% to 27,165 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| May 14, 2026 | Sale | John Rondoni (Chief Product and Innovation Officer) sold 700 shares at about $43.01 ($30K). Holdings down 2% to 29,806 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 15, 2026 |
| May 8, 2026 | Planned (10b5-1) | Shawn mcCormick (Director) sold 696 shares at $45.31 ($32K), marked as a 10b5-1 plan trade. Holdings down 2% to 27,712 shares. | SEC filing Filed May 11, 2026 |
| Jan 9, 2026 | Planned (10b5-1) | John Rondoni (Chief Product and Innovation Officer) sold 109 shares at $100.00 ($11K), marked as a 10b5-1 plan trade. Holdings down 1% to 13,797 shares. | SEC filing Filed Jan 12, 2026 |
| Dec 2, 2025 | Planned (10b5-1) | Shawn mcCormick (Director) sold 1,200 shares at $139.00 ($167K), marked as a 10b5-1 plan trade. Holdings down 5% to 24,846 shares. | SEC filing Filed Dec 4, 2025 |
| Nov 28, 2025 | Planned (10b5-1) | Shawn mcCormick (Director) sold 2,000 shares at $127.48 ($255K), marked as a 10b5-1 plan trade. Holdings down 7% to 26,046 shares. | SEC filing Filed Dec 1, 2025 |
| May 8–Aug 8, 2025 | Sale | Myriam Curet (Director) sold 6 shares between May 8, 2025 and Aug 8, 2025 at about $102.59 ($616). Holdings down <1% to 3,365 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 24, 2025 |
| Mar 20–Apr 7, 2025 | Purchase (code P) | Myriam Curet (Director) bought 5 shares between Mar 20, 2025 and Apr 7, 2025 at about $160.72 ($804), reported as a purchase (code P). Holdings up <1% to 3,371 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 24, 2025 |
45 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 4:29 PM ET 8-K | Earnings released (Item 2.02) Reg FD disclosure (Item 7.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow INSP in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.